A major breakthrough in cancer investigation is emerging with the use of VHH fragments to restore dysfunctional p53. This crucial cancer protector protein is frequently disabled in many forms of tumors, causing https://nybookmark.com/story23915173/mini-antibodies-reactivate-p53-the-new-hope-for-cancer-management